Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R Potter

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Lasers in Surgery and Medicine|January 1, 1993
Absence of rhodamine 123-photochemotoxicity in human tumor xenograftsH B Ris, H J Altermatt, T Schaffner, et al.
Photochemistry and Photobiology|April 1, 1987
Photobleaching of porphyrins used in photodynamic therapy and implications for therapyT S Mang, T J Dougherty, W R Potter, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Purpurinimides as photosensitizers: effect of the presence and position of the substituents in the in vivo photodynamic efficacyA Rungta, G Zheng, J R Missert, et al.
Cancer Research|February 1, 1985
Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapyB W Henderson, S M Waldow, T S Mang, et al.
Urology|September 1, 1985
Whole bladder photodynamic therapy for transitional cell carcinoma of bladderU O Nseyo, T J Dougherty, D G Boyle, et al.
Journal of Clinical Laser Medicine & Surgery|September 5, 1998
Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experienceU O Nseyo, J DeHaven, T J Dougherty, et al.
Photochemistry and Photobiology|August 1, 1997
Correlation between site II-specific human serum albumin (HSA) binding affinity and murine in vivo photosensitizing efficacy of some Photofrin componentsT Tsuchida, G Zheng, R K Pandey, et al.
Photochemistry and Photobiology|November 24, 1999
Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapyW R Potter, B W Henderson, D A Bellnier, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Photoradiation therapy--clinical and drug advancesT J Dougherty, D G Boyle, K R Weishaupt, et al.
Lasers in Surgery and Medicine|March 14, 2002
2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapyJ Lobel, I J MacDonald, M J Ciesielski, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Lasers in Surgery and Medicine|January 1, 1993
Absence of rhodamine 123-photochemotoxicity in human tumor xenograftsH B Ris, H J Altermatt, T Schaffner, et al.
Photochemistry and Photobiology|April 1, 1987
Photobleaching of porphyrins used in photodynamic therapy and implications for therapyT S Mang, T J Dougherty, W R Potter, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2000
Purpurinimides as photosensitizers: effect of the presence and position of the substituents in the in vivo photodynamic efficacyA Rungta, G Zheng, J R Missert, et al.
Cancer Research|February 1, 1985
Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapyB W Henderson, S M Waldow, T S Mang, et al.
Urology|September 1, 1985
Whole bladder photodynamic therapy for transitional cell carcinoma of bladderU O Nseyo, T J Dougherty, D G Boyle, et al.
Journal of Clinical Laser Medicine & Surgery|September 5, 1998
Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: a long-term experienceU O Nseyo, J DeHaven, T J Dougherty, et al.
Photochemistry and Photobiology|August 1, 1997
Correlation between site II-specific human serum albumin (HSA) binding affinity and murine in vivo photosensitizing efficacy of some Photofrin componentsT Tsuchida, G Zheng, R K Pandey, et al.
Photochemistry and Photobiology|November 24, 1999
Parabolic quantitative structure-activity relationships and photodynamic therapy: application of a three-compartment model with clearance to the in vivo quantitative structure-activity relationships of a congeneric series of pyropheophorbide derivatives used as photosensitizers for photodynamic therapyW R Potter, B W Henderson, D A Bellnier, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Photoradiation therapy--clinical and drug advancesT J Dougherty, D G Boyle, K R Weishaupt, et al.
Lasers in Surgery and Medicine|March 14, 2002
2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapyJ Lobel, I J MacDonald, M J Ciesielski, et al.
Pageof 4